27 results on '"Peyvandi, Sanam"'
Search Results
2. Tumor-educated [Gr1.sup.+][CD11b.sup.+] cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticity
3. NLRP1-dependent activation of Gasdermin D in neutrophils controls cutaneous leishmaniasis.
4. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
5. The β-carboline harmine has a protective immunomodulatory role in nonhealing cutaneous leishmaniasis
6. Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticity.
7. Supplementary Figures from Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
8. Supplementary Materials and Methods from Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
9. Figure S5 from Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
10. Supplemental figure legends from Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
11. Data from Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
12. Tumor-educated Gr1+CD11b+cells instigate breast cancer metastasis by twisting cancer cells plasticity via OSM/IL6–JAK signaling
13. Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
14. Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer
15. Chemotherapy-induced immunological breast cancer dormancy: a new function for old drugs?
16. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
17. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
18. Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade
19. A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
20. Les cellules Myéloïdes Dans le Microenvironnement Tumoral : Rôle de FasL
21. Myeloid cells in tumoral microenvironnement : Rôle of Fas ligand
22. Hypermethylated circulating DNA detection using picoliter droplet-based PCR in colorectal cancer.
23. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
24. Mo1939 Performance of a Blood Methylated Mutitarget DNA Test (Colohybritest) for the Diagnosis of Colorectal (CRC) Cancer: A Transversal Study on 878 Individuals
25. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
26. Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade
27. Establishing and Characterizing Chemotherapy-Induced Immunological Dormant Tumor Cell Lines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.